Akero Therapeutics, Inc. Capitalization, Long-term Debt and Equity
Akero Therapeutics, Inc. had Capitalization, Long-term Debt and Equity of $35.00 million as of 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes
us-gaap:CapitalizationLongtermDebtAndEquity · last filed 2025-02-28
- 2024-12-31: Capitalization, Long-term Debt and Equity $35.00M.
- 2024-09-30: Capitalization, Long-term Debt and Equity $35.00M.
- 2024-06-30: Capitalization, Long-term Debt and Equity $35.00M.
- 2024-03-31: Capitalization, Long-term Debt and Equity $35.00M.
| Period end | Capitalization, Long-term Debt and Equity |
|---|---|
| 2024-12-31 | $35.00M 10-K · filed 2025-02-28 |
| 2024-09-30 | $35.00M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $35.00M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $35.00M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $25.00M 10-K · filed 2024-02-29 |